{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Zhejiang%20Tianyu%20Pharmaceutical%20Co.%2C%20Ltd.","name":"Zhejiang Tianyu Pharmaceutical Co., Ltd.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-07T14:45:41.750Z"},"count":1,"matches":[{"id":"1bc209374022ab76","posted_date":"2022-09-27","letter_issue_date":"2022-08-17","company_name":"Zhejiang Tianyu Pharmaceutical Co., Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Active Pharmaceutical Ingredient (API)/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/1bc209374022ab76"}]}